The Extracellular Vesicles of the Helminth Pathogen, Fasciola hepatica: Biogenesis Pathways and Cargo Molecules Involved in Parasite Pathogenesis by Cwiklinski, Krystyna et al.
The Extracellular Vesicles of the Helminth
Pathogen, Fasciola hepatica: Biogenesis
Pathways and Cargo Molecules Involved in
Parasite Pathogenesis*□S
Krystyna Cwiklinski‡b, Eduardo de la Torre-Escudero‡b, Maria Trelis§¶,
Dolores Bernal∥, Philippe J. Dufresne**, Gerard P. Brennan‡, Sandra O’Neill‡‡,
Jose Tort§§, Steve Paterson¶¶, Antonio Marcilla§¶, John P. Dalton‡,
and Mark W. Robinson‡∥∥a
Extracellular vesicles (EVs) released by parasites have
important roles in establishing and maintaining infection.
Analysis of the soluble and vesicular secretions of adult
Fasciola hepatica has established a definitive character-
ization of the total secretome of this zoonotic parasite.
Fasciola secretes at least two subpopulations of EVs that
differ according to size, cargo molecules and site of re-
lease from the parasite. The larger EVs are released from
the specialized cells that line the parasite gastrodermus
and contain the zymogen of the 37 kDa cathepsin L pep-
tidase that performs a digestive function. The smaller
exosome-like vesicle population originate from multive-
sicular bodies within the tegumental syncytium and carry
many previously described immunomodulatory molecules
that could be delivered into host cells. By integrating our
proteomics data with recently available transcriptomic
data sets we have detailed the pathways involved with EV
biogenesis in F. hepatica and propose that the small exo-
some biogenesis occurs via ESCRT-dependent MVB for-
mation in the tegumental syncytium before being shed
from the apical plasma membrane. Furthermore, we
found that the molecular “machinery” required for EV
biogenesis is constitutively expressed across the intra-
mammalian development stages of the parasite. By con-
trast, the cargo molecules packaged within the EVs are
developmentally regulated, most likely to facilitate the
parasites migration through host tissue and to counteract
host immune attack. Molecular & Cellular Proteomics
14: 10.1074/mcp.M115.053934, 3258–3273, 2015.
The trematode parasite, Fasciola hepatica is the causative
agent of liver fluke disease (fasciolosis) in domestic animals.
F. hepatica infects more than 300 million cattle and 250 million
sheep worldwide resulting in losses of over $3 billion to global
agriculture through lost productivity (1). Fasciolosis is also an
important zoonotic disease with an estimated 2.6 million peo-
ple infected worldwide; human infection is particularly highly
prevalent in Egypt and the Andes of South America, while
outbreaks regularly occur in Northern Iran (2).
Infection in animals and humans can last many years while
adult parasites reside in the bile ducts. F. hepatica are obli-
gate blood feeders and obtain blood by puncturing the bile
duct wall. The regular regurgitation of parasite gut contents is
thought to inject molecules into the bloodstream where they
can exert an immunosuppressive activity on the host immune
system (3). Other molecules are secreted from the gut, excre-
tory pores and surface tegument into the bile where they may
be carried to the exterior via the host intestine (4–6). We, and
others, have previously used proteomic techniques to profile
the secretome of adult F. hepatica (7–10) but these studies
had a number of limitations: (1) they relied on very limited
transcriptome data sets with considerable redundancy; (2)
because genome sequence data was lacking it was not pos-
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sible to determine precisely the identity and/or the number of
the genes contributing to various secreted protein families; (3)
the contribution of extracellular vesicles to fluke secretions
was not investigated. However, our recent report of the Fas-
ciola genome and associated transcriptome data sets (11) has
now allowed us to address these limitations and perform a
definitive characterization of the total secretome of adult F.
hepatica. This is timely, given the report of exosome-like EVs
released by adult F. hepatica (12).
Extracellular vesicles (EVs)1 are small membrane bound
organelles that are shed by most cell types. Although once
considered to be “cellular garbage cans” with the sole pur-
pose of discarding unwanted cellular material (13), EVs are
now recognized as important mediators of intercellular com-
munication by transferring molecular signals, including pro-
teins, lipids, mRNA, microRNA and other non-coding RNA
species (14, 15). Variously described as exosomes or mi-
crovesicles depending on their cellular origin and mode of
biogenesis, EVs perform a variety of roles in the maintenance
of normal physiology such as blood coagulation, immune
regulation and tissue repair (16–18), but also participate in
pathological settings, notably in tumor progression (19). A
number of recent studies have shown that parasite-derived
EVs play an important role during infection. For instance, EVs
released by the helminth parasites Heligmosomoides po-
lygyrus and Schistosoma japonicum are capable of modulat-
ing the response of host innate immune cells (20, 21).
Here, we report the deep analysis of the soluble and vesic-
ular components of the adult F. hepatica secretome. We
found that F. hepatica secretes at least two subpopulations of
EVs that differ according to size, cargo molecules and poten-
tial site of release from the parasite. Using a proteomic ap-
proach, integrated with newly available F. hepatica genome
and transcriptome resources (11), we have defined the protein
composition of these two classes of vesicle and non-vesicle
associated proteins. The larger 15K EVs are released from the
specialized cells that line the parasite gastrodermus and con-
tain, as a marker, the 37 kDa inactive zymogen of the cathep-
sin L1 digestive peptidase. In contrast, our analysis of the
smaller 120K exosome-like vesicle population suggest that
they are shed from the tegument of adult fluke. Although the
120K EV biogenesis “machinery” is constitutively expressed
across the intramammalian developmental stages of the par-
asite, the cargo molecules packaged within the EVs are highly
regulated, most likely to facilitate the parasites migration
through host tissue and to counteract host immune attack.
EXPERIMENTAL PROCEDURES
Experimental Design and Statistical Rationale—Western blots and
fluorogenic assays were performed with at least two biological repli-
cates and three technical triplicates. For the proteomics study, whole
Fasciola EVs were initially analyzed by LC-MS/MS (two technical
replicates). These identifications were subsequently mapped to the
surface/membrane/lumen of the EVs following analysis of the EV
fractions, which were run without replicates because of the paucity of
parasite material. The aim of this experiment was to profile the mol-
ecules associated with fluke EVs and no quantitation was performed.
Isolation of Adult F. hepatica Extracellular Vesicles—Adult F. he-
patica parasites were obtained from bovine livers from local abattoirs.
To prepare secretions, adult flukes were thoroughly washed with PBS
to void their gut contents and then maintained in RPMI 1640 culture
medium containing 0.1% glucose, 100 U penicillin and 100 mg/ml
streptomycin (Sigma), at 2 worms/ml for 5 h at 37 °C. EVs were
purified according to the differential centrifugation protocol described
by Marcilla et al. (12). Briefly, after the incubation period, the parasite
culture media was collected and centrifuged at low speed (first at
300  g/10 min, and then at 700  g/30 min) to remove large debris.
The resulting supernatant was centrifuged at 15,000 g for 45 min at
4 °C to obtain large vesicles. Culture supernatants were then filtered
using a 0.2 m ultrafiltration membrane, and centrifuged at 120,000
g/1 h at 4 °C to recover smaller vesicles that were subsequently
washed with PBS.
Immunoblot Analysis of the EVs and Secretome—The protein con-
tent of adult fluke soluble secretions and EVs was determined using
the BCA protein assay kit (Pierce, Loughborough, UK). Equal amounts
(5 g) of each sample were run on reducing NuPage Novex 4–12%
Bis-Tris gels (Life Technologies), and transferred to nitrocellulose
membranes (GE Healthcare, Paisley, UK) at 120 mA for 45 min.
Following transfer, the membranes were incubated in blocking solu-
tion (TBST: 20 mM Tris-HCl, 150 mM NaCl, 1% Tween-20, pH 7.6)
containing 5% skimmed milk for 2 h at room temperature (18–21 °C).
Blots were probed with a 1:15,000 dilution of sheep antiserum raised
against recombinant F. hepatica peroxiredoxin (FhPrx; 22) or recom-
binant cathepsin L1 (FhCL1; Dalton, unpublished); a 1:1000 dilution of
rabbit antiserum raised against recombinant helminth defense mole-
cule (FhHDM-1; 23) or a 1:5000 dilution of rabbit antiserum raised
against recombinant Schistosoma mansoni leucine aminopeptidase
which is reactive to F. hepatica leucine aminopeptidase (SmLAP; 24,
Dalton unpublished) for 2 h at room temperature (18–21 °C). After
washing in TBST (3  10 min), an appropriate alkaline phosphatase-
conjugated IgG secondary antibody was applied to the membranes
for 1 h at room temperature (18–21 °C) before detection using the
BCIP/NBT substrate (Sigma).
Trypsin Shaving and Sequential Extraction of Purified F. hepatica
EVs—Peptides from surface-accessible proteins were released by
trypsin hydrolysis of EVs isolated from adult F. hepatica using our
previously described protocol (25). Briefly, sequencing grade trypsin
(Promega, Southampton, UK) was added to purified F. hepatica EVs
at a final concentration of 50 g/ml for 5 min at 37 °C. The treated EVs
were then centrifuged at 100,000 g for 1 h at 4 °C, and the released
peptides recovered from the supernatant.
To investigate subvesicular protein localization, purified F. hepatica
EVs were sequentially extracted to identify proteins associated with
the EV membrane or those contained within the EV lumen. First, the
EVs were resuspended in water; the resulting osmotic shock causes
1 The abbreviations used are: EV, extracellular vesicle; NEJ,
newly excysted juvenile; HDM, helminth defence molecule; CB,
cathepsin B; CL, cathepsin L; LAP, leucine aminopeptidase; Prx,
peroxiredoxin; FaBP, fatty acid-binding protein; GST, glutathione
transferase; MVB, multivesicular body; ESCRT, endosomal sorting
complex required for transport; DAMP, damage-associated molec-
ular pattern.
Data access statement: Genomic and transcriptomic data are avail-
able from the European Nucleotide Archive under the accession
numbers PRJEB6687 and PRJEB6904 respectively. The mass spec-
trometry proteomics data have been deposited to the Proteome-
Xchange Consortium via the PRIDE partner repository with the data
set identifier PXD002570.
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the EVs to burst and release the soluble contents held within the EV
lumen. The EV membranes were collected by centrifugation at
100,000 g for 1 h at 4 °C, while the soluble contents of the EV lumen
were recovered in the supernatant. The membrane pellet was se-
quentially extracted with 0.1 M Na2CO3 (pH 11) on ice for 30 min to
extract peripheral proteins and the sample centrifuged at 100,000 
g for 1 h at 4 °C. The final pellet was then solubilized in 1% Triton
X-100/2% SDS for 15 min at 37 °C to produce integral membrane
protein fractions (26).
Mass Spectrometry Analysis of EV and Secretome Fractions—
Proteins in the various EV fractions were reduced with 2 mM DTT in 50
mM NH4HCO3 (60 °C/20 min) and alkylated with 5 mM iodoacetamide
(room temperature (18–21 °C) in the dark/30 min). Samples were then
incubated with 100 ng/l sequencing grade trypsin (Promega) (37 °C/
overnight). The digestions were stopped by the addition of trifluoro-
acetic acid (TFA) to a final concentration of 0.1% and dried in a
vacuum centrifuge. The final mixtures were reconstituted with 10 l of
0.1% TFA before analysis by LC-MS/MS. Five microliters of the
resulting suspension were delivered to an analytical column (Eksigen
C18-CL NanoLC Column, 3 m; 75 m  15 cm) equilibrated in 5%
acetonitrile/0.1% formic acid (FA). Elution was carried out with a linear
gradient of 5–35% buffer B in buffer A for 30min (buffer A: 0.1% FA;
buffer B: acetonitrile, 0.1% FA) at a flow rate of 300 nl/min. Peptides
were analyzed in a nanoESI qQTOF mass spectrometer (5600 Trip-
leTOF, ABSCIEX) operating in information-dependent acquisition
mode, in which a 0.25-s TOF MS scan from 350–1250 m/z, was
performed, followed by 0.05-s product ion scans from 100–1500 m/z
on the 50 most intense 2–5 charged ions. Peak list files were gener-
ated by Protein Pilot v4.5 (Applied Biosystems) using default param-
eters and exported to Mascot v2.4.1 (Matrix Science) for database
searching.
Database Searching—All MS/MS samples were analyzed using
Mascot v2.4.1 (Matrix Science). Mascot was set up to search a
database comprised of the gene models identified within the F. he-
patica genome (version 1.0, 101,780 entries; 11) assuming trypsin
digestion with 1 missed cleavage permitted. The F. hepatica gene
model sequences can be accessed through WormBase ParaSite
(http://parasite.wormbase.org/) under accession PRJEB6687
(genomic read data and gene model transcripts). Mascot was
searched with a fragment ion mass tolerance of 0.1 Da and a parent
ion tolerance of 0.1 Da. Iodoacetamide derivative of cysteine was
specified in Mascot as a fixed modification. Glu-pyro-Glu of the N
terminus, Gln-pyro-Glu of the N terminus, deamidation of Asn and
Gln and oxidation of Met were specified in Mascot as variable
modifications.
Criteria for Protein Identification—Scaffold (version Scaffold_4.3.0,
Proteome Software Inc.) was used to validate MS/MS based peptide
and protein identifications. Peptide identifications were accepted if
they could be established at greater than 95.0% probability by the
Peptide Prophet algorithm (27) with Scaffold delta-mass correction.
Protein identifications were accepted if they could be established at
greater than 95.0% probability and contained at least two identified
peptides. Protein probabilities were assigned by the Protein Prophet
algorithm (28). Proteins that contained similar peptides and could not
be differentiated based on MS/MS analysis alone were grouped to
satisfy the principles of parsimony.
Analysis of the F. hepatica Transcriptome and Gene Models—RNA
sequencing and gene expression analysis was carried out for multiple
lifecycle stages, including metacercariae, NEJ 1, 3 and 24 h postex-
cystment, juvenile 21-day-old and adult liver flukes, as described by
Cwiklinski et al. (11). Briefly, Illumina TruSeq RNA libraries were
prepared and sequenced, with the resulting RNAseq data being
mapped to F. hepatica genome scaffolds and gene models. Differen-
tial expression analysis in edgeR was carried out for all genes to
which at least five Illumina reads across all libraries could be mapped.
Discovery of F. hepatica genes associated with EV machinery was
carried out using BLAST analysis against the F. hepatica genome.
Briefly, human proteins, inferred from the literature to have roles in
exosome biogenesis, cargo sorting or uptake, were used as BLAST
queries to identify homologs in closely-related trematode species
(NCBI; trematoda). Both the human proteins and trematode homologs
were used as BLAST queries to interrogate the F. hepatica genome
(NCBI v2.2.29). Each match was manually validated and confirmed
using InterPro (http://www.ebi.ac.uk/interpro/) which detects the
presence of conserved protein domains. Expression of these identi-
fied genes across the F. hepatica lifecycle was investigated using the
differential expression analysis of all the gene models identified within
the genome. Hierarchical clustering using Gene Cluster 3.0 (29) was
used to group differentially expressed genes by similarity of expres-
sion, graphically represented using heat-maps.
Analysis of Peptidase Activity in EVs—The soluble contents of F.
hepatica EVs recovered following the 15,000  g and 120,000  g
centrifugation of fluke culture media were isolated by osmotic shock.
Briefly, the vesicle pellets were resuspended in hypotonic buffer (20
mM HEPES-KOH; pH 7.3) and placed on ice for 30 min with intermit-
tent vortexing followed by sonication (5  20s at 20% power). The
vesicle membranes were then removed by centrifugation at 20,000 
g for 1 h at 4 °C. Auto-activation of the native procathepsin L was
carried out by incubating the soluble extract from the 15,000  g
vesicle pellet (50 g total protein) at 37 °C in 100 mM citrate phos-
phate buffer, pH 4.5, containing 1 mM DTT. Aliquots (15 l) were
removed at time intervals and added to tubes containing 1 l of 1 mM
E-64 to stop the reaction. Proteolytic cleavage of the prosegment was
visualized by immunoblotting as described above. Cathepsin L activ-
ity was also monitored in the presence of the fluorogenic peptide
substrate Z-Leu-Arg-NHMec (20 M) by measuring the release of
fluorescence over time using a Polarstar Omega micro-plate reader
(BMG Labtech) in 96-well fluorescent plates as previously described
(30). Cathepsin B activity was measured by incubating the soluble
vesicular extracts with Z-Arg-Arg-NHMec (10 M) in 100 mM citrate-
phosphate buffer (pH 6.5) containing 1 mM DTT and 0.01% Triton
X-100. E-64 (10 M) was used to inhibit cathepsin L and B activity.
Leucine aminopeptidase activity was measured by incubating the
vesicular extracts with the substrate H-Leu-NHMec (10 M) in 100 mM
Tris-HCl buffer (pH 7.5) containing 1 mM MnCl2 and 0.01% Triton
X-100. Bestatin (50 M), a broad-spectrum aminopeptidase inhibitor
(31) was used to demonstrate inhibition of the reaction.
Transmission Electron Microscopy—Transmission electron micros-
copy (TEM) was performed on adult flukes as previously described
(32). Briefly, adult flukes were fixed for 1 h in 2% double-distilled
glutaraldehyde (DDG; Agar Scientific) in 0.1 M sodium cacodylate
buffer (pH 7.2) containing 3% sucrose at 4 °C. After washing in buffer,
specimens were dehydrated in ethanol and embedded in Agar 100
resin (Agar Scientific, Stansted, UK). Ultrathin sections (60–70 nm)
were cut on a Reichert Ultracut E ultramicrotome and collected on
bare 200-mesh nickel grids. For immunogold labeling, sections were
etched with 10% hydrogen peroxide for 5 min then washed with 20
mM Tris-HCl buffer (pH 8.2) containing 0.1% bovine serum albumin
and 2.5% Tween 20. Grids were incubated in normal goat serum (1:20
dilution in Tris-HCl buffer) for 30 min and then transferred to primary
antibody diluted to 1:20,000 with 0.1% bovine serum albumin/Tris-
HCl buffer for 12–18 h. Grids were washed in bovine serum albumin/
Tris-HCl and then incubated with 10 nm gold-conjugated goat anti-
sheep IgG (Bio Cell International) for 2 h at room temperature (18–
21 °C). Grids were then lightly fixed with 2% DDG for 3 min, double
stained with uranyl acetate and lead citrate and examined in a FEI
(Philips) CM100 transmission electron microscope, operating at 100
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keV. Controls included omission of primary antibody and incubation
of grids with pre-immune serum followed by the secondary antiserum.
The exosome-like 120K vesicle pellet was analyzed by TEM as
previously described (12). The 15K vesicle pellet was resuspended in
PBS and aliquots placed on formvar-coated grids and examined in a
FEI (Philips) CM100 transmission electron microscope, operating at
100 keV.
RESULTS
Profiling the Total Secretome of Adult F. hepatica—Taking
advantage of our recently reported F. hepatica genome and
transcriptome data sets for the major intramammalian life-
cycle stages (newly excysted juveniles, NEJs; 21-day old
immature liver stage juveniles, and adult flukes) (11), we were
able to perform a definitive characterization of the secretions
of adult F. hepatica. Sixty-nine proteins secreted by adult F.
hepatica were identified in this analysis (supplemental Tables
S1 and S2). In accordance with previous transcriptomic anal-
yses (10, 11, 33) peptidases were highly represented (12
matches), including Pro-Xaa carboxypeptidases, cathepsin
L1 and L2 clade members, dipeptidylpeptidase III, cathepsin
A, legumain 2, metalloendopeptidases, and a cathepsin B.
Inhibitors of serine peptidases, serpin, and cysteine pepti-
dases, cystatin 1, were also identified. Another well repre-
sented functional group included molecules involved in de-
fense against immune effector cells (10 matches), comprising
helminth defense molecule (HDM), GST-mu and -sigma
classes, fatty acid binding protein (FABP Fh 2), thioredoxin
and thioredoxin-glutathione reductase. Other functional
groups included membrane structure (12 matches), recep-
tors/transporters (five matches), enzymes (seven matches),
metabolism (six matches), and 14 hits corresponded to pro-
teins with various/unknown functions. A large proportion of
the identified proteins (30%) possessed a predicted N-termi-
nal signal peptide, including the majority of the peptidases. Of
the remaining proteins, 57% did not contain a predicted sig-
nal peptide, whereas 13% could not be predicted because of
5 truncation of the transcripts.
Adult Fluke Culture Supernatants Contain Distinct Sub-
populations of EVs—Following ultracentrifugation, a homoge-
neous group of exosome-like EVs (post-120,000  g spin)
30–100 nm in diameter could be isolated from F. hepatica
culture media as confirmed by transmission electron micros-
copy (supplemental Fig. S1A, and 12). However, in the pres-
ent study we also recovered a pellet following the 15,000  g
centrifugation step that had been previously overlooked.
Transmission electron microscopy also revealed that this pel-
let contained membrane-bound vesicles 50–200 nm in diam-
eter (supplemental Fig. S1B–S1E). We performed a protein
assay to determine the relative contributions of the 15 K
pellet, the 120 K pellet, and the final post-120 K supernatant
to the total protein secreted by adult flukes. We determined
that adult F. hepatica secretes total protein at a rate of 17.3
g/fluke/hr (100%) of which 0.6 g/fluke/h (3.6%) is associ-
ated with the 120 K pellet, 1.5 g/fluke/hr (8.6%) is associated
with the 15 K pellet whereas the majority 15.2 g/fluke/hr
(87.8%) remains in solution following the 120 K spin. The
complexity of each fraction, as determined by 1D gel electro-
phoresis, can be observed in Fig. 1A. Each sample is defined
by a distinct protein profile indicating a compartmentaliza-
tion of the total secretome that can be separated by
centrifugation.
To investigate these fractions further, each fraction (5 g
total protein) was probed with specific antisera available in our
laboratory against a range of secreted Fasciola secreted mol-
ecules (Fig. 1B). Immunoblotting showed that bands corre-
sponding to helminth defense molecule (FhHDM; 6 kDa) were
detected across all samples with the most intense HDM stain-
ing observed in the 15 K pellet. We found the F. hepatica
leucine aminopeptidase (FhLAP; 55 kDa) and peroxiredoxin
(FhPrx; 24 kDa) in both the 15 K and 120 K vesicle pellets but
not in the total secretome or the 120 K supernatant. F. hepat-
ica cathepsin L1 (FhCL1), which is synthesized as an inactive
37 kDa zymogen (9), was revealed as an intense reactive band
in the 15 K vesicle pellet, but was barely visible by comparison
in the 120 K pellet. Although the 37 kDa zymogen was not
observed in the total secretome and final supernatant, a pro-
cessed mature 24 kDa cathepsin L containing the catalytic
domain was.
To confirm the above data, we used fluorogenic peptide
substrates to determine the relative peptidase activities asso-
ciated with the vesicle subpopulations (i.e. 15 K versus 120 K
pellets). Although leucine aminopeptidase activity, measured
using the substrate H-Leu-NHMec, was not detected in sol-
uble extracts from either pellet, strong H-Leu-NHMec hydrol-
ysis was observed when the membranes from both the 15 K
and 120 K pellets were incubated with the substrate. The
activity associated with membranes from the 120K pellet was
fourfold higher than that associated with the 15 K pellet mem-
branes in accordance with Acosta et al. (34). In all assays, this
leucine aminopeptidase activity was inhibited by bestatin, a
broad-spectrum aminopeptidase inhibitor (data not shown).
Equal amounts of total protein from each vesicle sample
were incubated with diagnostic substrates for cathepsin L
(Z-Leu-Arg-NHMec) and cathepsin B (Z-Arg-Arg-NHMec) ac-
tivities. Comparison of the hydrolysis of each fluorogenic sub-
strate within the linear range of the reactions (15 min) by each
extract is shown in Fig. 1C. Strong cathepsin activity was
detected in both 15 K and 120 K vesicle pellets. However,
both cathepsin B- and L-specific activity in extracts of the 120
K pellet were on average 60% less than that observed in
extracts of the 15 K pellet. In all assays, cathepsin B and L
activity were completely inhibited by 10 M E-64, a cysteine
peptidase inhibitor (data not shown).
The 15 K EVs are Derived from Gastrodermal Cells and
Contain Inactive Cathepsin L Zymogens that Can be Acti-
vated at low pH—Our immunoblot analysis of the centrifu-
gation fractions indicated that adult F. hepatica secretes a
population of relatively large vesicles (15 K pellet) enriched
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for the inactive 37 kDa cathepsin L zymogen (Fig. 1B). To
determine whether the native zymogen packaged within EVs
could undergo pH-dependent autocatalytic activation simi-
lar to our purified recombinant cathepsin Ls (35–37), soluble
extracts of the 15 K vesicle pellet were incubated at low pH
(pH 4.5) for up to 3 h at 37 °C. Western blot analysis of the
in vitro auto-activation process shows that the 37 kDa zy-
mogen diminishes over time, concomitant with the appear-
FIG. 1. Biochemical characterization of adult F. hepatica EV populations. A, Typical 1-D profile of the adult F. hepatica total secretome
(E/S), the 15 K pellet, the 120 K supernatant, and 120 K pellet. Proteins were separated using NuPage Novex 4–12% Bis-Tris gels (Life
Technologies), and stained with colloidal Coomassie blue G250. B, Immunoblot analysis of the above fractions using antibodies against F.
hepatica peroxiredoxin (Prx), cathepsin L1 (CL1), helminth defense molecule (HDM), and S. mansoni leucine aminopeptidase (LAP). C. Activity
of soluble extracts from the 15 K and 120 K vesicle pellets against a panel of diagnostic fluorescent substrates that measure cathepsin B,
cathepsin L and leucine aminopeptidase activity.
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ance of a band corresponding to the processed 24 kDa
mature enzyme (Fig. 2A; arrowed). The rate of formation of
an active mature enzyme from the inactive zymogen at pH
4.5 was rapid indicating that autocatalytic activation of the
native enzyme occurs readily in an acidic environment
(Fig. 2B).
Transmission electron microscopy showed the presence of
secretory vesicles densely packed within the specialized gas-
trodermal cells that line the fluke gut (Fig. 2C). Immunogold
labeling using anti-cathepsin L antibodies revealed that these
vesicles were intensely, and specifically, stained for F. hepat-
ica cathepsin L1 (Fig. 2D). No labeling was observed in any
other structures which indicates that the large vesicles of the
15 K pellet that are enriched for the 37 kDa cathepsin L1
zymogen originate from the gastrodermal cells of the fluke
gut.
The Proteome of F. hepatica 120 K Exosome-like EVs—A
proteomics analysis of the small exosome-like EVs (120 K
vesicle pellet) was performed taking advantage of the newly
available genome and transcriptome resources for F. hepatica
(11), to gain a deeper coverage of the EV proteome than
previously reported (12). Here, we performed a sequential
treatment to identify differentially located proteins in the
EVs. We first employed trypsin shaving (25) to release pro-
teins from the surface of the EVs, before sequentially ex-
tracting them to identify proteins associated with the EV
membranes as well as soluble proteins packaged within the
EV lumen. A total of 180 different EV proteins were identified
using this approach and their functional annotation is shown
in Tables I and II.
A number of well-known exosomal markers, including
Hsp70, ALIX and members of the tetraspanin family, were
identified during the proteomics analysis. This supports the
classification of the vesicles derived from the 120K pellet as
“exosome-like.” Peptidases were highly represented in the EV
proteome. Peptides corresponding to legumain 4/5, cathep-
sin A, cathepsin B6/8, and a Pro-Xaa carboxypeptidase were
released following trypsin shaving of the EV surface. Other
proteases, such as leucine aminopeptidase, various subunits
of the F. hepatica proteasome and several cathepsin Bs were
either found associated with the EV membrane (present in
carbonate washes), or within the EV lumen (present in the
soluble extract).
Several membrane channels, transporters and other mole-
cules associated with membrane structure were identified.
These included the ATPase pumps ABCB1/p-glycoprotein,
Na/K ATPase, and a phospholipid-transporting ATPase
(flippase). Membrane transporters such as anoctamin (a cal-
cium-activated chloride channel), Niemann-Pick C1, and C2
proteins (cholesterol transporters), an amino acid permease,
an inositol transporter and a glucose transporter were also
found. Other proteins with potential roles in membrane struc-
ture included various annexins and the F. hepatica T1 tegu-
mental antigen (38). In addition to components of the cyto-
skeleton, peptides corresponding to several metabolic
enzymes were released following trypsin shaving of the EV
FIG. 2. Gastrodermal cell-derived
EVs contain inactive cathepsin L zy-
mogens. A, Soluble extracts from the
15K vesicle pellet were incubated in 100
mM citrate phosphate buffer (pH 4.5) for
3 h at 37 °C. Aliquots of the reaction
mixtures were removed after 0, 30, 60,
120, and 180 min and halted with 10 M
E-64 on ice. Samples were then trans-
ferred to nitrocellulose membranes and
probed with an anti-Fasciola cathepsin
L1 antibody. The inactive zymogen (37
kDa) showed a progressive decrease in
intensity concurrent with the appearance
of a band representing the 24 kDa ma-
ture enzyme (arrowhead). B, The auto-
activation of FhCL1 shown in (A) was
analyzed by following the hydrolysis of
the fluorogenic dipeptide substrate Z-
Leu-Arg-NHMec over 60 min at 37 °C.
The autoactivation was inhibited in the
presence of 10 M E-64. C, Transmis-
sion electron micrograph (TEM) showing
secretory vesicles (arrowed) within the
specialized gastrodermal cells that line
the gut of adult F. hepatica. D, TEM
showing immunogold labeling for FhCL1
localized to the secretory vesicles within
a gastrodermal cell within the gut of
adult F. hepatica.
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TABLE I
Proteins associated with the membrane of EVs from adult F. hepatica. Figures represent number of unique peptides
Protein Identifier
Extract
Trypsin NaHCO3 TX100/SDS
Proteases & inhibitors
Legumain 4/5 BN1106_s1861B000097 7 12 0
Cathepsin B BN1106_s1772B000188 0 13 0
Cathepsin A BN1106_s1241B000264 3 7 0
Cathepsin B6/8 BN1106_s793B000177 2 5 0
Cathepsin B fragment BN1106_s8462B000006 0 4 0
Cathepsin B4/5/7 BN1106_s13444B000002 0 6 0
Cathepsin L1 BN1106_s8490B000026 0 5 0
Lysosomal Pro-X carboxypeptidase BN1106_s1620B000120 0 4 0
M17 Leucine aminopeptidase 2 BN1106_s617B000566 0 6 0
20S proteasome subunit alpha 6 BN1106_s1579B000119 0 4 0
Proteasome beta 1 subunit BN1106_s5855B000168 0 4 0
Proteasome subunit beta type-5 BN1106_s6770B000051 0 5 0
Proteasome subunit beta 2 BN1106_s2242B000188 0 5 0
Proteasome subunit alpha 7 BN1106_s7720B000057 0 3 0
Proteasome subunit alpha type BN1106_s4981B000066 0 6 0
Proteasome subunit alpha type BN1106_s3658B000104 0 4 0
20S proteasome subunit alpha 3 BN1106_s1639B000395 0 2 0
Lysosomal pro-Xaa carboxypeptidase BN1106_s3518B000132 2 3 0
Proteasome subunit alpha 6 BN1106_s1259B000205 0 3 0
M17 Leucine aminopeptidase 1 BN1106_s7079B000034 0 2 0
20S proteasome subunit beta 2 BN1106_s2284B000154 0 4 0
Cathepsin L1 BN1106_s10332B000011 0 3 0
Multicystatin (cys1) BN1106_s1612B000138 0 2 0
Proteasome subunit alpha type BN1106_s9050B000016 0 2 0
Pumps & transporters
ABCB1 BN1106_s274B000296 4 2 3
MDR p-glycoprotein 1 BN1106_s2471B000098 0 0 3
Glucose-transporter BN1106_s584B000350 0 0 2
Phospholipid-translocating ATPase IIB BN1106_s435B000242 0 0 3
ATP synthase subunit alpha BN1106_s4332B000087 0 2 0
Metabolism
Propionyl-CoA carboxylase alpha BN1106_s1252B000359 17 3 0
Glutamate dehydrogenase 1 NAD(P) BN1106_s5767B000030 5 6 0
Aldolase BN1106_s4469B000065 2 2 0
GAPDH BN1106_s5174B000030 5 0 0
Glutamine synthetase BN1106_s2400B000186 3 3 0
Propionyl-CoA carboxylase beta BN1106_s1551B000468 0 3 0
Malic enzyme BN1106_s233B000262 6 0 0
Hexokinase A BN1106_s175B000200 0 0 2
Retinol dehydrogenase BN1106_s2277B000049 0 0 2
Malate dehydrogenase BN1106_s1459B000183 3 0 0
Cytoskeleton
Actin 5C BN1106_s2907B000133 11 4 0
Ezrin BN1106_s1300B000145 2 0 2
Fimbrin BN1106_s1403B000129 7 2 0
Alpha actinin BN1106_s4069B000247 4 0 0
Gelsolin BN1106_s2349B000188 3 2 0
Beta tubulin 1 BN1106_s55B000372 3 0 0
Rho1 GTPase BN1106_s1908B000177 0 0 2
Chaperones
Ubiquitin-60S ribosomal protein L40 BN1106_s6576B000103 0 2 2
Hsp70 BN1106_s309B000234 9 2 3
Chaperonin containing tcp1 BN1106_s1242B000159 2 0 0
14–3-3 protein BN1106_s3904B000042 0 0 2
Exosome biogenesis / vesicle trafficking
Annexin BN1106_s819B000364 8 4 0
Tetraspanin-CD63 receptor BN1106_s1657B000161 0 5 4
Acid sphingomyelinase BN1106_s1285B000159 2 6 0
Annexin BN1106_s945B000218 2 9 7
Myoferlin BN1106_s3585B000136 0 0 11
Tetraspanin-1 BN1106_s915B000136 0 2 2
ALIX BN1106_s2963B000136 0 0 6
IST1 BN1106_s3747B000112 2 0 7
Otoferlin BN1106_s3261B000048 0 0 7
Vacuolar assembly/sorting protein D1D2-like protein BN1106_s2316B000077 0 0 5
ALIX BN1106_s1871B000313 0 0 4
Charged multivesicular body protein BN1106_s2655B000264 0 0 4
Vacuolar protein sorting-associated protein 4B BN1106_s1437B000141 0 0 4
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surface. These included propionyl-CoA carboxylase, gluta-
mate dehydrogenase, glutamine synthase, malic enzyme, and
malate dehydrogenase and GAPDH whereas other enzymes
were found associated with the EV membrane or within the EV
lumen. A small number of host-derived proteins were also
identified including immunoglobulins, casein, and acylamino-
acid-releasing enzyme (supplemental Table S3).
Comparison of our data sets for adult fluke total secretome
and the exosome-like EVs with the tegumental proteome re-
ported by Wilson et al. (6) revealed that there is an overlap in
protein expression between these samples (Fig. 3). Of the 180
proteins identified in the adult fluke EVs, 35 and 22 proteins
were shared with the total secretome and tegument, respec-
tively. A total of nine proteins were shared by the total secre-
tome and tegument, whereas only nine proteins were found in
all three samples. supplemental Fig. 2 shows the composition
of the total secretome and EV proteome dats sets grouped
according to function.
Transcriptome Profiling Reveals that Fasciola EV Biogenesis
Pathways are Constitutively Expressed While Cargo Mole-
cules are Developmentally Regulated—A significant number
of the proteins identified have roles in the endosomal path-
way, or in EV biogenesis, and provide insight into the mech-
anism used by F. hepatica to generate EVs. These include
various components of the ESCRT-dependent exosome bio-
genesis pathway (e.g. a number of charged multivesicular
body proteins, the AAA-ATPase Vps4, IST1, syntenin and
ALIX), and the ceramide-dependent pathway (e.g. sphingo-
myelinase). Several members of the Rab GTPase family, such
as Rab8a, Rab11b, and Rab27 that have roles in EV biogen-
esis and release were also found. Also identified were
SNAREs (synaptotagmin and VAMP7) as well as myoferlin and
otoferlin that mediate vesicle trafficking and fusion. A cartoon
summarizing the proteome of the exosome-like EVs from
adult fluke is shown in Fig. 4 and the full mass spectrometry
report is shown in supplemental Table S3.
To gain insight into the putative mechanism(s) of EV bio-
genesis in F. hepatica we conducted an extensive search of
the literature for proteins implicated in this process via func-
tional studies, largely in mammalian cells. A total of 102 pro-
TABLE I—continued
Protein Identifier
Extract
Trypsin NaHCO3 TX100/SDS
Syntenin-1 BN1106_s4740B000062 0 0 3
Rab8 BN1106_s258B000276 0 0 2
CD63 antigen BN1106_s4560B000072 0 2 0
Charged multivesicular body protein 5 BN1106_s6543B000070 0 0 5
Vacuolar protein sorting 26 BN1106_s1191B000313 0 0 2
Vacuolar protein sorting-associated protein VTA1 BN1106_s2858B000111 0 0 2
Annexin B2 BN1106_s500B000161 0 0 2
Antioxidant/Defence
Peroxiredoxin BN1106_s1614B000280 0 3 2
Secreted saposin-like protein SAP-3 BN1106_s10326B000017 0 4 0
Thioredoxin BN1106_s4026B000080 0 3 2
GST sigma class BN1106_s1081B000242 0 2 0
Carrier proteins
Major vault protein BN1106_s7273B000042 0 8 0
Ferritin BN1106_s3950B000041 0 3 5
Niemann-Pick C2 protein BN1106_s20469B000004 0 2 0
Ferritin BN1106_s709B000627 0 5 0
Myoglobin BN1106_s284B000287 0 3 2
Enzymes
Phosphodiesterase-nucleotide pyrophosphatase BN1106_s1985B000403 0 4 3
Carbonic anhydrase BN1106_s3009B000044 0 3 3
Alpha mannosidase BN1106_s666B000200 0 3 0
Ras-related protein Ral-A BN1106_s637B000246 0 0 2
Alpha-galactosidase BN1106_s1241B000260 0 2 0
Uncharacterized / other
F. hepatica tegumental antigen-1 AF153056 6 0 3
DM9 domain-containing protein BN1106_s5689B000026 2 4 4
Calmodulin-like protein BN1106_s678B000118 0 2 0
Uncharacterized BN1106_s3001B000132 0 5 5
Uncharacterized BN1106_s8038B000016 0 4 7
Uncharacterized BN1106_s4767B000028 0 2 3
Uncharacterized BN1106_s6821B000024 0 2 4
Uncharacterized BN1106_s440B000226 0 0 4
Uncharacterized BN1106_s1110B000106 0 2 2
Uncharacterized BN1106_s114B000615 0 2 2
Uncharacterized BN1106_s4767B000027 0 0 2
Uncharacterized BN1106_s4413B000122 0 4 0
Uncharacterized BN1106_s551B000321 0 0 3
Uncharacterized BN1106_s263B000609 0 4 0
Uncharacterized BN1106_s3381B000140 0 2 0
Uncharacterized BN1106_s739B000132 0 0 2
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TABLE II
Top 50 proteins identified within the lumen of EVs released by adult F. hepatica
Protein ID Identifier Unique Peptides
Proteases
Legumain 4/5 BN1106_s1861B000097 14
Cathepsin A BN1106_s1241B000264 11
Cathepsin B BN1106_s1772B000188 8
M17 Leucine aminopeptidase 2 BN1106_s617B000566 8
Cathepsin B6/8 BN1106_s793B000177 7
Cathepsin L1 BN1106_s8490B000026 7
20S proteasome subunit alpha 6 BN1106_s1579B000119 7
Cathepsin B4/5/7 BN1106_s13444B000002 6
Lysosomal Pro-X carboxypeptidase BN1106_s1620B000120 6
Proteasome subunit beta type-5 BN1106_s6770B000051 6
20S proteasome subunit alpha 3 BN1106_s1639B000395 6
M17 Leucine aminopeptidase 1 BN1106_s7079B000034 5
Membrane structure
Annexin BN1106_s819B000364 17
Myoferlin BN1106_s3585B000136 14
Tetraspanin-CD63 receptor BN1106_s1657B000161 8
Annexin BN1106_s945B000218 8
Tetraspanin-1 BN1106_s915B000136 8
Otoferlin BN1106_s3261B000048 8
T-cell immunomodulatory protein BN1106_s92B000560 7
Annexin BN1106_s3266B000046 6
EV biogenesis
ALIX BN1106_s2963B000136 9
Acid sphingomyelinase BN1106_s1285B000159 8
IST1 BN1106_s3747B000112 7
Vacuolar protein sorting-associated protein 4B BN1106_s1437B000141 7
ALIX BN1106_s1871B000313 6
Rab8 BN1106_s258B000276 6
Rab11b BN1106_s844B000259 6
Channels and transporters
ABCB1 BN1106_s274B000296 30
Na/K transporting ATPase subunit alpha BN1106_s521B000167 12
Niemann-Pick disease type C1 protein BN1106_s1498B000257 10
MDR p-glycoprotein 1 BN1106_s2471B000098 8
vATPase subunit I BN1106_s18772B000008 8
Inositol transporter BN1106_s3611B000052 7
Enzymes
Phosphodiesterase-nucleotide pyrophosphatase BN1106_s1985B000403 9
Aldolase BN1106_s4469B000065 9
Peroxiredoxin BN1106_s1614B000280 5
Enolase BN1106_s3227B000227 8
Glutamate dehydrogenase 1 NAD(P) BN1106_s5767B000030 7
Beta-1,4-galactosyltransferase 2 BN1106_s741B000214 6
Uncharacterized/other
Major vault protein BN1106_s7273B000042 15
Uncharacterized BN1106_s8038B000016 11
Actin 5C BN1106_s2907B000133 10
Uncharacterized BN1106_s3001B000132 9
DM9 domain-containing protein BN1106_s5689B000026 7
Uncharacterized BN1106_s216B000184 7
Uncharacterized BN1106_s6821B000024 6
Uncharacterized BN1106_s440B000226 6
Ferritin BN1106_s3950B000041 6
Ezrin BN1106_s1300B000145 6
14–3-3 protein BN1106_s3904B000042 5
The Extracellular Vesicles of Fasciola hepatica
3266 Molecular & Cellular Proteomics 14.12
teins were identified and categorized according to their role in
vesicle formation including: components of the endosomal
sorting complexes required for transport (ESCRT) pathway,
components of the ceramide pathway, roles in EV release
(Rabs and SNAREs), RNA/protein/lipid sorting and membrane
fusion/repair (supplemental Table 4). These proteins were
used as queries to interrogate the newly available F. hepatica
genome (11). All components of the ESCRT machinery, ex-
cept for the charged multivesicular body protein 6 (CHMP6)
from the ESCRT-III complex, were present in the F. hepatica
genome. The ESCRT pathway was also well represented at
the proteome level with up to ten putative members identified
during the MS analysis of adult fluke exosome-like EVs; most
of them were components of the ESCRT-III and Vps4 com-
plexes that have roles in multivesicular body (MVB) formation
and the final membrane budding/abscission steps during the
latter stages of EV biogenesis (39). BLAST results also
showed that many components of ESCRT-independent path-
ways for exosome release are present in the fluke genome but
less widely represented at the proteome level. The most sig-
nificant matches of the MS data include acid sphingomyeli-
nase and tetraspanin CD63, that are both involved in exo-
some biogenesis in mammalian cells.
Having identified putative homologs of the EV biogenesis
pathway members in F. hepatica, we then examined their
relative expression levels across the intramammalian lifecycle
stages of F. hepatica. Transcriptome data sets for Fasciola
NEJs at 1 h, 3 h, and 24 h time-points postexcystment were
used as well as 21-day old immature liver-stage flukes and
adult flukes from the bile duct (11). Relative transcript expres-
sion levels (fold change on a log2 scale) are shown as a
heat-map in Fig. 5. Taking this broad view, it is apparent that,
with a few exceptions, putative EV biogenesis pathway mem-
bers in F. hepatica are constitutively expressed (albeit at low
levels), and do not differ greatly in expression levels as the
parasite migrates from the small intestine, through the liver
and into the bile ducts. However, when we performed the
same analysis of the transcripts encoding the remaining pro-
teins identified during our proteomics analysis of adult fluke
exosome-like EVs (i.e. those not implicated in EV biogenesis
and thus termed putative cargo molecules), we found that
most were expressed at higher levels and were developmen-
tally regulated. As can be seen in the heat-map shown in Fig.
6, the transcripts can be broadly segregated into two groups:
(1) those with low levels of expression in the NEJ stage that
increase in the 21-day old and adult flukes, and (2) those with
high levels of expression in the NEJ stage that decrease in the
21-day old and adult flukes. Group one members included
several proteases such as legumain 4/5, Pro-Xaa carboxy-
peptidase, cathepsin B4/5/7 and members of cathepsin L
clades 1, 2, and 5. Others included saposin-like and CD59-
like proteins, a calcium-binding protein, and a range of highly
expressed, but uncharacterized, proteins. Notable group two
members included thioredoxin, peroxiredoxin, cathepsin B2,
various proteasome subunits and metabolic enzymes such
as enolase, malate dehydrogenase, and propionyl CoA
carboxylase.
DISCUSSION
The recent availability of new -omics resources for F. he-
patica permitted us to conduct the most comprehensive anal-
ysis of any helminth secretome to date. We have discovered
that adult F. hepatica secretions are more complex than pre-
viously thought, and contain at least two subpopulations of
EVs that differ according to size, cargo and mechanism of
release from the parasite. In doing so we have challenged the
classic view that soluble proteins are the sole mediators of the
host-parasite interaction and identified new mechanisms by
which parasite-derived molecules can interact with host cells.
These mechanisms can be classed under various headings:
(1) Extracellular interaction with host macromolecules. In
terms of protein content, soluble molecules made the greatest
contribution to the adult fluke total secretome (87.8%). This
fraction is dominated by members of the cathepsin L cysteine
peptidase family which represent 80% of the total protein
secreted (8–10). Fasciola cathepsin Ls perform a variety of
roles, mostly associated with extracellular degradation of host
macromolecules such as collagen to aid parasite migration
through host tissues (36, 37), hemoglobin as a source of
nutrition (30) and immunoglobulins to avoid expulsion by the
host immune system (40). The considerable expenditure de-
voted to secretion of soluble proteins by F. hepatica clearly
shows that these tasks are critical for completion of the par-
asite’s life-cycle. (2) Endocytosis of soluble parasite mole-
cules. We have shown that cathepsin L1 and helminth de-
fense molecule (HDM), which are both present as soluble
proteins within F. hepatica secretions, are internalized via the
endolysosomal pathway and modulate host macrophage
function by degradation of toll-like receptor 3 and inhibition of
vacuolar-ATPase respectively (26, 41). The receptors required
for uptake of these molecules are currently unknown however
FIG. 3. Expression of proteins in the tegument, total secretome
and EVs of adult F. hepatica. Venn diagram comparing the proteins
identified in the total secretome and extracellular vesicles (EVs) re-
leased by adult F. hepatica (this study), and those found in tegumental
fractions (tegument) by Wilson et al. (6).
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HDM binds to cholesterol within lipid rafts on the cell surface
that may initiate internalization (26). (3) Internalization of par-
asite EVs. Although we estimate that the 15 K and 120 K EV
pellets hold only 8.6% and 3.6% of the total protein secreted
by adult F. hepatica, respectively, they contain potent immu-
nomodulators/virulence factors (see below) that would exert
greater effects on host cell function than their abundance
might suggest. EVs secreted by adult flukes will drain, via the
bile ducts, into the host gut and we have shown that fluke
exosome-like EVs are internalized by host intestinal epithelial
cells (IECs) in vitro (12). Although traditionally regarded as a
mere physical barrier to infection, IECs are now known
to express pattern-recognition receptors that enable them to
detect a range of microbial ligands and transmit signals to
underlying gut-associated lymphoid tissues (42). Thus, para-
site-derived EVs could maintain a systemic Th2/regulatory
environment that is permissive to fluke survival and reproduc-
tion via modulation of IEC immune surveillance.
We, and others, have shown that several proteins released
by F. hepatica have the ability to modulate host immune cell
function (43). In this study we have found the majority of these
immunomodulators are packaged within the exosome-like
EVs secreted by adult fluke. Although F. hepatica peroxire-
doxin (Prx) actively drives host Th2 immune responses via
stimulation of M2 macrophages (44, 45), most of the other
fluke immunomodulators identified so far (despite displaying
varied structures and biochemical activities), indirectly pro-
mote Th2 responses by suppressing the development of Th1/
Th17-associated inflammation. These include Fasciola hel-
minth defense molecule (HDM), cathepsin L1 (FhCL1), fatty
acid-binding protein (FABP), kunitz-type molecule (Fh-KTM)
and Sigma class glutathione transferase (GST) (23, 41, 46–
48). The role of F. hepatica Prx in switching the host immune
response to a Th2 phenotype during the early stages of in-
fection has been well documented (44, 45). This is in agree-
ment with our transcriptome profiling of EV cargo molecules
(Group 2, Fig. 6). However, our transcriptomics and proteo-
mics profiling experiments have shown that the remaining
immunomodulators (FhCL1, HDM, FABP, Fh-KTM, and GST
sigma) are constitutively expressed across the intramamma-
lian life-cycle stages of the fluke and are actually up-regulated
as the flukes migrate through the liver, enter the bile ducts and
mature into adult worms (10,11; Group 1, Fig. 6). These ob-
servations suggest that the latter molecules act to maintain
the Th2/regulatory phenotype seen during chronic infection.
Thus, EV cargo molecules, as well as components of the
soluble secretome of adult F. hepatica (10) are developmen-
tally regulated to facilitate the parasites migration through
host tissue and to counteract host immune attack. Work is
ongoing in our laboratory to characterize the EVs secreted by
the NEJ stage.
We have also identified potential immunomodulators not
previously thought to be secreted by adult F. hepatica, the
most notable being members of the cathepsin B family. Sev-
eral cathepsin B transcripts were previously identified in adult
flukes, but these enzymes were not detected in the adult fluke
secretome and therefore it was suggested that they have
intracellular house-keeping roles (10). However, we have
found that the small exosome-like EVs contain at least four
developmentally regulated cathepsin B peptidases. This find-
ing establishes that both cathepsin L and B peptidases are
secreted by adult flukes, albeit via different mechanisms, the
former via the gut and the latter via the tegument. Studies in
Schistosoma mansoni have shown that a cathepsin B,
FIG. 4. Summary of the proteome of adult F. hepatica exosome-like EVs.
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SmCB2, is located in the tegument of the adult parasites (49).
Also identified, within the EV lumen, were a number of lead-
erless proteins (including Prx, heat shock proteins and annex-
ins) that are homologs of host damage-associated molecular
pattern molecules (DAMPs). DAMPs are leaderless cytosolic
proteins that are released into the extracellular environment
via atypical secretory pathways in response to tissue damage
(50). They interact with pattern recognition receptors ex-
pressed by immune cells and thus set off an “alarm” system
which often leads to a wound-healing scenario (50). Be-
cause of their abundance within helminth secretions, we
previously speculated that DAMP homologs can direct the
FIG. 5. Expression of transcripts encoding putative EV biogenesis pathway members across the intramammalian lifecycle stages of
F. hepatica. Heatmaps are colored on a log2 scale with up-regulation in red and down-regulation in blue relative to metacercariae, depicting
log fold change between developmental stages, grouped by hierarchical clustering. The F. hepatica life-cycle stages analyzed are: newly
excysted juveniles (NEJ; 1-, 3- and 24-h postexcystment), 21-day old immature liver-stage flukes (Juv_21d), and adult flukes from the bile duct.
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host immune response (51) and their packaging into EVs
provides an alternative route for their non-canonical secre-
tion. Although the mechanism for targeting cytosolic pro-
teins into EVs is not fully understood, ATP-binding cassette
(ABC) transporters are responsible for packaging some
leaderless proteins (e.g. FGF1, IL-1, and Hsp70) into EVs
destined for secretion (52–54). We identified two ABC trans-
porters associated with the F. hepatica EV membrane
FIG. 6. Expression of transcripts encoding putative EV cargo proteins across the intramammalian life cycle stages of F. hepatica.
Heatmaps are colored on a log2 scale with up-regulation in red and down-regulation in blue relative to metacercariae, depicting log fold change
between developmental stages, grouped by hierarchical clustering. The F. hepatica life cycle stages analyzed are: newly excysted juveniles
(NEJ; 1-, 3- and 24-h postexcystment), 21-day-old immature liver-stage flukes (Juv_21d), and adult flukes from the bile duct.
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(ABCB1 and p-glycoprotein 1) that may perform similar
packaging roles in the parasite.
The recently available F. hepatica genome (11) has allowed
us, for the first time, to identify pathways involved in EV
biogenesis in a helminth parasite. Exosomes arise from the
endosomal system and are formed by inward budding of the
multi-vesicular body (MVB) membrane that allows capture of
cytoplasmic cargo. This step is thought to occur via two
different routes. Endosomal sorting complexes required for
transport (ESCRT) 0, I, II, and III, together with syntenin-ALIX
complexes, capture ubiquitinated proteins, whereas in the
ESCRT-independent pathway tetraspanins (e.g. CD63) and
various lipid-related enzymes (notably sphingomyelinase) can
also drive vesicle formation (55, 56). The final abscission of
the budding exosomes into the MVB lumen requires the AAA-
ATPase VPS4 (57). The exosomes are then secreted into the
extracellular space following the fusion of the MVB with the
plasma membrane, which is dependent on small GTPases
including Rab8b, Rab11, Rab27a, and Rab27b and the Rab
effectors otoferlin and synaptotagmin-like protein (58–61).
We identified F. hepatica homologs of all these key regulators
of exosome biogenesis during our proteomics analysis of the
120 K EV pellet (summarized in Fig. 4). However, it is signifi-
cant that although the ESCRT pathway was well represented
at the proteome level (10 members were identified in the MS
analysis), the only representatives of the lipid-related/ESCRT-
independent pathway were sphingomyelinase and tetraspa-
nin CD63 (supplemental Table S4). Based on these findings
we propose that exosome biogenesis in adult fluke primarily
occurs via ESCRT-dependent MVB formation in the tegumen-
tal syncytium with the exosomes being shed from the apical
plasma membrane (although functional studies such as RNAi
are needed to confirm this). In support of this proposal, MVBs
have been described during ultrastructural examination of the
tegumental syncytia of F. hepatica and the related trematode
E. caproni (6, 12). Furthermore, our comparative proteomics
analysis revealed that 42% of the proteins identified in the F.
hepatica tegumental extracts by Wilson et al. (6) were also
packaged into the 120 K EVs; these contained a variety of
proteins (e.g. tegumental antigen 1, DM9-containing protein,
annexin, and tetraspanin) that localize primarily within the
tegument of F. hepatica and related trematodes (6, 38, 62–
64). Determining the specific roles of individual pathway
members during exosome biogenesis in liver fluke needs
further investigation, perhaps by RNAi-mediated gene silenc-
ing which is functional in this parasite (65).
Targeting key regulators of EV biogenesis (including sphin-
gomyelinase, ALIX and Rab GTPases) using chemical inhibi-
tors or RNAi has been shown to significantly reduce the
number of EVs released by mammalian cells. Indeed, sup-
pressing EV production to inhibit their effect in disease is an
emerging therapeutic strategy that has yielded impressive
results, notably in cancer therapy (reviewed by 14). We have
identified F. hepatica homologs of several key regulators of EV
biogenesis that could be targeted for parasite control if spe-
cific inhibitors can be found. Although technically challenging,
selective inhibition of parasite EV biogenesis would prevent
the delivery of a range of immunomodulators to host cells
and, conceivably, tip the host immune balance in favor of
Th1-driven parasite elimination. An alternative anti-parasite
control strategy would be to block the uptake of parasite-
derived EVs by host cells. Although direct fusion of EVs with
the plasma membrane of target cells has been reported (66),
uptake mechanisms akin to receptor-mediated endocytosis
(dependent on the complement of proteins expressed on the
vesicle surface) appear to be the dominant route of entry into
recipient cells (67). Many of the proteins we identified on the
external surface of F. hepatica EVs are metabolic enzymes, or
other housekeeping proteins, with reported “moonlighting”
roles in other helminths and microbial pathogens (68). These
include malic enzyme, enolase, GAPDH, aldolase and annexin
which act as parasite adhesion molecules via interaction with
plasminogen and/or fibronectin on the host cell surface (69–
74) and could be targets for blocking antibodies. Recently, it
was shown that antibodies against O. viverrini tetraspanin
blocked uptake of parasite EVs by host cholangiocytes, pro-
viding proof-of-concept, at least mechanistically, for this ap-
proach as an anti-parasite therapy (75).
In this report we have performed the first comparative anal-
ysis of the soluble and vesicular secretions of a helminth para-
site. This was made possible by integrating the recently avail-
able genome, transcriptome, and proteome data sets for this
pathogen (11). Our study underscores the importance of inves-
tigating the role of EVs during acute and chronic fluke infection
and presents new opportunities to disrupt EV biogenesis or
interaction with target cells toward parasite control.
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